Aflac Re Bermuda Ltd. recently agreed to reinsure a block of whole life annuities from Japan Post Insurance Co. Ltd. through coinsurance, while Aflac also introduced a new Group Life Term to 120 product in the U.S. with an innovative long-term care rider. Together, these moves highlight Aflac’s push to pair aging‑population solutions in the U.S. with deeper risk‑sharing partnerships in Japan’s insurance market. Next, we’ll examine how Aflac’s hybrid life‑and‑long‑term‑care product could influence its investment narrative around product innovation and earnings stability.
Capitalize on the AI infrastructure supercycle with our selection of the 36 best ‘picks and shovels’ of the AI gold rush converting record-breaking demand into massive cash flow.
Aflac Investment Narrative Recap
To own Aflac, you need to believe in its ability to monetize aging‑population needs while managing pressure on Japan premiums, margins and yen translation. The new Japan Post Insurance reinsurance deal and U.S. long‑term‑care life product look directionally aligned with that story but do not materially change the near term catalyst of stabilizing Japanese premium trends or the key risk of weaker investment income and currency‑driven earnings volatility.
The launch of Group Life Term to 120 with a long‑term care rider in the U.S. stands out here, because it directly targets rising long‑term care costs at worksite, tying into Aflac’s broader effort to revive U.S. sales growth and diversify earnings away from Japan while having only modest immediate impact on the current earnings and margin pressures management is working through.
Yet investors should also be aware that Aflac’s heavy reliance on Japan leaves results sensitive to yen moves and low investment returns…
Read the full narrative on Aflac (it’s free!)
Aflac’s narrative projects $18.0 billion revenue and $3.8 billion earnings by 2029. This requires 1.5% yearly revenue growth and an earnings increase of about $0.2 billion from $3.6 billion today.
Uncover how Aflac’s forecasts yield a $113.00 fair value, in line with its current price.
Exploring Other Perspectives
AFL 1-Year Stock Price Chart
Two fair value estimates from the Simply Wall St Community range widely, from US$113 to about US$177, underscoring how differently people view Aflac’s prospects. You should weigh those opinions against the ongoing decline in Japanese earned premiums, which could limit how quickly the business can grow overall.
Explore 2 other fair value estimates on Aflac – why the stock might be worth just $113.00!
Reach Your Own Conclusion
Don’t just follow the ticker – dig into the data and build a conviction that’s truly your own.
Curious About Other Options?
Don’t miss your shot at the next 10-bagger. Our latest stock picks just dropped:
This article by Simply Wall St is general in nature. We provide commentary based on historical data
and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your
financial situation. We aim to bring you long-term focused analysis driven by fundamental data.
Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material.
Simply Wall St has no position in any stocks mentioned.
New: Manage All Your Stock Portfolios in One Place
We’ve created the ultimate portfolio companion for stock investors, and it’s free.
• Connect an unlimited number of Portfolios and see your total in one currency
• Be alerted to new Warning Signs or Risks via email or mobile
• Track the Fair Value of your stocks
Try a Demo Portfolio for Free
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com
AloJapan.com